John Burns
Direttore Finanziario/CFO presso SELLAS LIFE SCIENCES GROUP, INC.
Patrimonio netto: 39 368 $ in data 30/04/2024
Posizioni attive di John Burns
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Comptroller/Controller/Auditor | 30/12/2017 | - |
| Direttore Finanziario/CFO | 30/12/2017 | - |
Storia della carriera di John Burns
Precedenti posizioni note di John Burns
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PIXELWORKS, INC. | Corporate Officer/Principal | - | - |
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Comptroller/Controller/Auditor | 23/02/2016 | - |
Formazione di John Burns
| Tulane University (Louisiana) | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| 2 |
Posizioni
| Comptroller/Controller/Auditor | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
| Electronic Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PIXELWORKS, INC. | Electronic Technology |
| Aziende private | 2 |
|---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
| SELLAS Life Sciences Group, Inc. |
- Borsa valori
- Insiders
- John Burns
- Esperienza
